$GTCH News: SAN DIEGO, Jan. 27, 2022 (GLOBE NEWSWIRE) --

New Post Public Reply Private Reply Replies (0) Message Board
budfoxfun
160
$GTCH News: SAN DIEGO, Jan. 27, 2022 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), is evaluating the use of advanced NLP algorithm model to enhance its AI based healthcare advisory system human interaction experience. The Text-To-Text Transfer Transformer (T5) model introduces an efficient technology to perform a wide variety of supervised Natural Language Processing (NLP) tasks such as classification, Q&A and summarization. Typically, most of the new deep learning NLP models are very large and include vast number of parameters. Normally the larger the NLP model, the more learning capacity it has, yet one of the main disadvantages is the huge dataset which may reduce the overall performance. The advanced NLP algorithm model is considered one of the most advanced, high performance NLP algorithms that includes a vast number of parameters, using significantly less memory, and provides high accuracy. GBT will be evaluating the T5, pre-trained model with the goal of using it in its Hippocrates healthcare advisory system, handling Q/A, text, summarization and compositional commonsense knowledge. The model allows more parallel processing than methods like Recurrent Neural Network (RNN) and Convolutional Neural Network (CNN) which significantly increases data understanding and reasoning capabilities. For example, T5 model is capable of processing words together rather than on a word-by-word of a given text. As global data realm is estimated to reach zettabytes range in the near future, our deep learning computing will need powerful processing capabilities, comprehending and scrutinizing data, particularly in the huge, unstructured NLP domain. The system is designed to perform as a general health Q/A advisory system, providing first-line of health-related advice. We plan to further develop the system to include intelligent telemedicine capabilities that will assist patients and healthcare specialists through global connected devices.

“Natural Language processing (NLP) is currently broadly used for the various tasks involving sentiment analysis, for example spam email detection, textual/voice driven virtual assistants, chatbots, and similar. In the last decade, deep learning technology have become more powerful, allowing larger data and faster processing models to handle the constantly growing unstructured data. The amount of unstructured data has become a challenge for information analysis especially within the NLP arena due to compositional complexity and the demand for a human-alike interaction. Today’s voice and text digital assistants are expected to efficiently “understand” verbal or textual conversations, exactly as an in-person interaction. Artificial General Intelligence (AGI) is our machine learning solution to “understand” the data, reason and make decisions exactly as a human would do. One of the key challenges for such system is to comprehend humans natural language, interpret, and manipulate it, which is exactly what NLP is. Our Avant! deep neural networks already encapsulate vast computing power, allowing larger language models with faster processing. We are seeking new capabilities by combining new NLP models with our current technology to better “understand” users, their intent, and providing accurate, well summarized, response. We are evaluating if the possible implementation of the T5 model within our Hippocrates healthcare AI system may produce much more robust level of user’s chat interaction with more human-alike dialog, mainly intuitive. The Hippocrates healthcare advisory system is aimed to provide first line health related advice and to become an assisting tool for the general population and healthcare professionals. Its human interaction aspect, via a robust NLP technology, is one of the most important features to ensure viable and accurate health related advice information” provided Danny Rittman, the Company’s CTO.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

New CMO Joins ARTHEx: Boosting Innovative RNA Focus

Updated Category News Views 26

ARTHEx Biotech's Strategic Expansion Looks like ARTHEx Biotech is shaking things up with some strategic moves by bringing in Dr. Christian Freitag as their new Chief Medical Officer. Now, if you’re knee-deep in the biotech game, you'll know that having someone like Freitag onboard is akin to adding a star player to your lineup. The guy's got more than two decades of...

Continue Reading
Zinzino's October Sales Report: Eye on the Nutritional Prize

Updated Category News Views 38

Delving Into Zinzino's October Performance Alright, let’s cut to the chase and dive headfirst into what really matters—Zinzino AB’s preliminary sales report for October 2026. If you’re banking on the thriving nutritional supplement sector, this Swedish company’s numbers might just be your radar’s blip. October wasn’t just any month for these folks; it was a...

Continue Reading
Are BWIN, LFCR, PCRX Shareholder Deals Fair?

Updated Category News Views 113

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

Continue Reading
Starting Pet End-of-Life Talks: Why Timing Matters

Updated Category News Views 23

Early Conversations Can Change Everything The minute you bring it up, let's be honest, nobody likes to talk about end-of-life decisions, not even for their pets. Yet, when you think about it, biding your time until things get critical isn't doing anyone any favors, especially not the furry ones. Drs. Brandon and Paola Beebout, two piercing minds from Kearney, Nebraska,...

Continue Reading
Kendra Scott's 'Long Live Joy' Campaign Dazzles

Updated Category News Views 40

Unveiling a Holiday Spectacle: 'Long Live Joy' Party hats off, folks, because Kendra Scott is stepping up the holiday game with something they’re calling 'Long Live Joy'. Now, we're not just talking about any run-of-the-mill marketing fluff. This one’s big, it’s colorful, and it’s here to make your accessorized holidays a tad more enchanting. The Multi-Faceted...

Continue Reading
RideNow Gears Up for Earnings Amidst Industry Shifts

Updated Category News Views 185

Highway to Earnings: RideNow's Third Quarter Call Alright, folks, this is the moment the powersports crowd has been itching for. RideNow Group, Inc. (NASDAQ: RDNW) is set to roll out their third-quarter financial results on November 10, 2026. If you're in for a wild ride—pun fully intended—mark this on your calendars. With this company hogging the spotlight in the...

Continue Reading
Duolingo Faces Class Action: Investors React Strongly

Updated Category News Views 63

Duolingo's Rough Road: A Lawsuit in Motion Alright, fasten your seatbelts, because we've got a real rollercoaster here with Duolingo (NASDAQ: DUOL). You know, the language-learning app that's been pushing ads like it's going out of style? Well, investors are seeing red—not the kind you want, either. This class action lawsuit looming over them is like an unwelcome...

Continue Reading
Crocs™ Gains C2C Circularity Gold for Classic Clogs

Updated Category News Views 81

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Continue Reading
Baidu Faces Fraud Allegations: What Investors Should Know

Updated Category News Views 196

Trouble on the Horizon for Baidu Shareholders If you've got a pulse in the world of stock trading, you've likely caught wind of the storm brewing over at Baidu, Inc. (NASDAQ: BIDU). We're talking some heavy-duty allegations of securities fraud, and a class action lawsuit that's got investors scrutinizing their portfolios like never before. The lawsuit's been filed in the...

Continue Reading
AllianceBernstein Unveils Income-Focused ETF Amid Volatile Times

Updated Category News Views 40

Diving into AllianceBernstein's New Income ETF Well, today we’ve got something stirring in the financial waters over at AllianceBernstein. They’ve launched a new exchange-traded fund (ETF), aptly named the AB Equity Premium Income ETF [INK]. Now, if you’re wondering what’s cooking with this newcomer on the NASDAQ, let’s crack it open and see what’s under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Keyo Elevates Rudy Dajie to CEO, Driving Innovative Payments

Updated Category News Views 237

Keyo Appoints Rudy Dajie as New CEO for Advanced Payment Solutions Keyo has recently announced a game-changing leadership appointment with Rudy Dajie stepping into the role of Chief Executive Officer. In a world where artificial intelligence is rapidly evolving, the demand for enhanced security in biometric identification is greater than ever. Innovative Biometric...

Continue Reading
Final Call for $XPL Token Access: Join the XploraDEX Journey

Updated Category News Views 162

Final Chance to Participate in $XPL Token Distribution The $XPL token distribution is entering its crucial final phase, marking an exciting moment for both investors and traders. As the presale of XploraDEX nears its closing date, many are eager to grab their share of the tokens before the opportunity slips away. This innovative platform, set on the XRP Ledger, has the...

Continue Reading
Promising Small-Cap Stocks on the Rise for Investors

Updated Category News Views 73

Small-Cap Stocks on the Verge of Growth As 2024 progresses, many analysts have identified a resurgence in small-cap stocks, suggesting that this year could mark a turning point for these often-overlooked companies. With the economic landscape shifting, especially as interest rates stabilize, there is renewed hope for sectors that faced challenges in previous years....

Continue Reading
Eli Lilly's New Oral Diabetes Treatment Python Results Exceed Expectations

Updated Category News Views 204

Eli Lilly's Groundbreaking Diabetes Treatment Trials Eli Lilly and Company (NYSE: LLY) has made significant advancements in the treatment of type 2 diabetes with their oral medication, orforglipron. Recent Phase 3 trials, ACHIEVE-2 and ACHIEVE-5, have demonstrated impressive results in controlling blood sugar levels among participants. ACHIEVE Trials Overview The...

Continue Reading
Experience Luxury and Performance with the 2025 LC 500 Convertible

Updated Category News Views 63

Introducing the 2025 LC 500 Convertible The 2025 LC 500 Convertible marks another exciting development in the luxury automobile market, maintaining its prestige and allure. This model has undergone a few updates and is ready to impress enthusiasts and casual drivers alike. Standout Features of the 2025 Model This year's model comes with notable enhancements, including...

Continue Reading